
Which Weight Loss Drug for this Complex Patient?
She is 35 y/o with a history of migraine, bipolar disorder, and hypertension. Years of structured diets and nutrition consult have failed. Which agent would you consider?
A 35-year-old woman presents to your office for assistance with weight loss. She has tried structured diets through a registered dietician for the past year with minimal weight loss. She has a history of frequent migraines, bipolar disorder, and hypertension. Her medications include phenelzine, fluoxetine, lithium, lisinopril, and sumatriptan. Currently, her BMI is 32 kg/m2 and her blood pressure is 152/96 mm Hg
Which drug or drug combination would be most appropriate for weight loss in this patient?
A. Orlistat
B. Bupropion-naltrexone
C. Phentermine-topiramate
D. Lorcaserin
E. Liraglutide
Answer: A. Orlistat.
Lorcaserin is a selective agonist of the serotonin 2C receptor which in turn suppresses appetite. Lorcaserin should not be used alongside selective serotonin reuptake inhibitors, monoamine oxidase inhibitors, or triptans.
Liraglutide is useful in obese patients who have co-morbid type 2 diabetes, which this patient does not have.
Phentermine-topiramate can cause fetal anomalies and is not the drug of choice in women of childbearing age and is also contraindicated in patients with poorly controlled hypertension, bupropion-naltrexone should also be avoided in poorly controlled hypertension.
------------------------------------------
Suggested reading : Bray GA, Ryan DH.
Newsletter
Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.










































































































































































































































































































